| 1 |
34961309 | Shape-Memory ECM-Mimicking Heparin-Modified Nanofibrous Gelatin Scaffold for Enhanced Bone Regeneration in Sinus Augmentation. | 2022 Jan 10 |
2 |
| 2 |
33409509 | BMP-2 delivery strategy modulates local bone regeneration and systemic immune responses to complex extremity trauma. | 2021 Mar 10 |
1 |
| 3 |
33819813 | Programmed BMP-2 release from biphasic calcium phosphates for optimal bone regeneration. | 2021 May |
1 |
| 4 |
31115719 | Improving the Osteogenicity of PCL Fiber Substrates by Surface-Immobilization of Bone Morphogenic Protein-2. | 2020 Mar |
1 |
| 5 |
32688092 | Effects of controlled dual growth factor delivery on bone regeneration following composite bone-muscle injury. | 2020 Sep 15 |
1 |
| 6 |
33463282 | Engineering a Self-Assembling Leucine Zipper Hydrogel System with Function-Specific Motifs for Tissue Regeneration. | 2020 May 11 |
4 |
| 7 |
30565254 | Heparin is biocompatible and can induce differentiation of human dental pulp cells. | 2019 Jun |
2 |
| 8 |
31027908 | Enhancing cell seeding and osteogenesis of MSCs on 3D printed scaffolds through injectable BMP2 immobilized ECM-Mimetic gel. | 2019 Jul |
3 |
| 9 |
31210206 | Development of CaCO3 microsphere-based composite hydrogel for dual delivery of growth factor and Ca to enhance bone regeneration. | 2019 Aug 20 |
2 |
| 10 |
29597024 | Design of hydrogels to stabilize and enhance bone morphogenetic protein activity by heparin mimetics. | 2018 May |
4 |
| 11 |
29702734 | Heparin-dopamine functionalized graphene foam for sustained release of bone morphogenetic protein-2. | 2018 Jun |
2 |
| 12 |
30205243 | Minimum structural requirements for BMP-2-binding of heparin oligosaccharides. | 2018 Nov |
4 |
| 13 |
33435067 | Controlled Release of BMP-2 from a Heparin-Conjugated Strontium-Substituted Nanohydroxyapatite/Silk Fibroin Scaffold for Bone Regeneration. | 2018 Sep 10 |
3 |
| 14 |
28104757 | Analysis and identification of the Grem2 heparin/heparan sulfate-binding motif. | 2017 Mar 8 |
2 |
| 15 |
28645809 | Enhanced in vivo retention of low dose BMP-2 via heparin microparticle delivery does not accelerate bone healing in a critically sized femoral defect. | 2017 Sep 1 |
4 |
| 16 |
27042064 | Sustained dual release of placental growth factor-2 and bone morphogenic protein-2 from heparin-based nanocomplexes for direct osteogenesis. | 2016 |
1 |
| 17 |
27098389 | Is Heparin Effective for the Controlled Delivery of High-Dose Bone Morphogenetic Protein-2? | 2016 May |
4 |
| 18 |
27383886 | A new biocompatible delivery scaffold containing heparin and bone morphogenetic protein 2. | 2016 Sep 1 |
1 |
| 19 |
27585207 | Polyelectrolyte Complex for Heparin Binding Domain Osteogenic Growth Factor Delivery. | 2016 Aug 22 |
1 |
| 20 |
24764177 | Controlled release of BMP-2 using a heparin-conjugated carrier system reduces in vivo adipose tissue formation. | 2015 Feb |
1 |
| 21 |
25705961 | Novel Protamine-Based Polyelectrolyte Carrier Enhances Low-Dose rhBMP-2 in Posterolateral Spinal Fusion. | 2015 May 1 |
1 |
| 22 |
25736498 | Bioactive cell-derived matrices combined with polymer mesh scaffold for osteogenesis and bone healing. | 2015 May |
1 |
| 23 |
26231738 | Fabrication of a BMP-2-immobilized porous microsphere modified by heparin for bone tissue engineering. | 2015 Oct 1 |
2 |
| 24 |
26462137 | Hierarchical Nanofibrous Microspheres with Controlled Growth Factor Delivery for Bone Regeneration. | 2015 Dec 9 |
3 |
| 25 |
26474791 | Mode of heparin attachment to nanocrystalline hydroxyapatite affects its interaction with bone morphogenetic protein-2. | 2015 Dec 16 |
7 |
| 26 |
24881028 | Heparin microparticle effects on presentation and bioactivity of bone morphogenetic protein-2. | 2014 Aug |
4 |
| 27 |
25263872 | Improving osteoblast functions and bone formation upon BMP-2 immobilization on titanium modified with heparin. | 2014 Dec 19 |
5 |
| 28 |
32262010 | Magnetic biopolymer nanogels via biological assembly for vectoring delivery of biopharmaceuticals. | 2014 Dec 21 |
3 |
| 29 |
22894570 | Enhanced control of in vivo bone formation with surface functionalized alginate microbeads incorporating heparin and human bone morphogenetic protein-2. | 2013 Feb |
1 |
| 30 |
23135410 | Evaluation of collagen/heparin coated TCP/HA granules for long-term delivery of BMP-2. | 2013 Feb |
2 |
| 31 |
23341458 | The factor VII-activating protease (FSAP) enhances the activity of bone morphogenetic protein-2 (BMP-2). | 2013 Mar 8 |
1 |
| 32 |
23641914 | Copolymerization of 2-methylene-1,3-dioxepane and glycidyl methacrylate, a well-defined and efficient process for achieving functionalized polyesters for covalent binding of bioactive molecules. | 2013 Jun 10 |
1 |
| 33 |
23888776 | [A novel human bone morphogenetic protein-7 variant with an enriched heparin-binding site]. | 2013 May-Jun |
2 |
| 34 |
23987380 | The effect of titanium with heparin/BMP-2 complex for improving osteoblast activity. | 2013 Oct 15 |
1 |
| 35 |
22824487 | Prediction of heparin binding sites in bone morphogenetic proteins (BMPs). | 2012 Dec |
4 |
| 36 |
23407680 | Periplasmic Expression of a Novel Human Bone Morphogenetic Protein-7 Mutant in Escherichia coli. | 2012 Oct |
1 |
| 37 |
20880582 | The effect of immobilization of heparin and bone morphogenic protein-2 (BMP-2) to titanium surfaces on inflammation and osteoblast function. | 2011 Jan |
1 |
| 38 |
20504805 | Customized Ca-P/PHBV nanocomposite scaffolds for bone tissue engineering: design, fabrication, surface modification and sustained release of growth factor. | 2010 Oct 6 |
1 |
| 39 |
20596760 | Heparinized hydroxyapatite/collagen three-dimensional scaffolds for tissue engineering. | 2010 Aug |
1 |
| 40 |
18286621 | Enhancement of the biological activity of BMP-2 by synthetic dextran derivatives. | 2009 Jan |
5 |
| 41 |
18083224 | The effect of crosslinking heparin to demineralized bone matrix on mechanical strength and specific binding to human bone morphogenetic protein-2. | 2008 Mar |
2 |
| 42 |
18317699 | Bone morphogenetic protein-2 enhances bone regeneration mediated by transplantation of osteogenically undifferentiated bone marrow-derived mesenchymal stem cells. | 2008 Jul |
1 |
| 43 |
18449905 | Heparin inhibits BMP-2 osteogenic bioactivity by binding to both BMP-2 and BMP receptor. | 2008 Sep |
7 |
| 44 |
18773307 | Enhancement of ectopic bone formation by bone morphogenetic protein-2 delivery using heparin-conjugated PLGA nanoparticles with transplantation of bone marrow-derived mesenchymal stem cells. | 2008 Nov |
3 |
| 45 |
19216269 | Bone formation on apatite-coated titanium incorporated with bone morphogenetic protein and heparin. | 2008 Nov-Dec |
1 |
| 46 |
17350678 | Enhancement of ectopic bone formation by bone morphogenetic protein-2 released from a heparin-conjugated poly(L-lactic-co-glycolic acid) scaffold. | 2007 Jun |
2 |
| 47 |
18688288 | Multifunctional hydrogels that promote osteogenic hMSC differentiation through stimulation and sequestering of BMP2. | 2007 |
1 |
| 48 |
16709187 | Heparin/heparan sulphate binding in the TGF-beta cytokine superfamily. | 2006 Jun |
1 |
| 49 |
16754660 | Heparin potentiates the in vivo ectopic bone formation induced by bone morphogenetic protein-2. | 2006 Aug 11 |
5 |
| 50 |
15045531 | [Evaluation of the osteoinductive potential of genetically modified BMP-2 variants]. | 2004 Mar |
1 |